KDF1, a Novel Tumor Suppressor in Clear Cell Renal Cell Carcinoma

KDF1 has been identified as a key regulator of epidermal proliferation and differentiation, but it is unknown whether KDF1 is involved in the pathogenesis of malignancy. No study has reported the expression and function of KDF1 in renal cancer. To explore the pathologic significance of KDF1 in clear...

Full description

Bibliographic Details
Main Authors: Jing-min Zheng, Mei-fu Gan, Hong-yuan Yu, Lu-xia Ye, Qing-xin Yu, Yu-hui Xia, Han-xi Zhou, Jia-qian Bao, Yi-qing Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.686678/full
id doaj-d44a32e4203c429d8c68db7271b5daa7
record_format Article
spelling doaj-d44a32e4203c429d8c68db7271b5daa72021-05-31T07:57:15ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-05-011110.3389/fonc.2021.686678686678KDF1, a Novel Tumor Suppressor in Clear Cell Renal Cell CarcinomaJing-min Zheng0Jing-min Zheng1Mei-fu Gan2Hong-yuan Yu3Lu-xia Ye4Qing-xin Yu5Yu-hui Xia6Han-xi Zhou7Jia-qian Bao8Yi-qing Guo9Department of Urology, Taizhou Hospital, Wenzhou Medical University, Linhai, ChinaDepartment of Pathology, Taizhou Hospital, Wenzhou Medical University, Linhai, ChinaDepartment of Pathology, Taizhou Hospital, Wenzhou Medical University, Linhai, ChinaDepartment of Urology, Taizhou Hospital, Wenzhou Medical University, Linhai, ChinaDepartment of Pathology, Taizhou Hospital, Wenzhou Medical University, Linhai, ChinaDepartment of Pathology, Taizhou Hospital, Wenzhou Medical University, Linhai, ChinaDepartment of Pathology, Taizhou Hospital, Wenzhou Medical University, Linhai, ChinaDepartment of Urology, Taizhou Hospital, Wenzhou Medical University, Linhai, ChinaDepartment of Urology, Taizhou Hospital, Wenzhou Medical University, Linhai, ChinaDepartment of Urology, Taizhou Hospital, Wenzhou Medical University, Linhai, ChinaKDF1 has been identified as a key regulator of epidermal proliferation and differentiation, but it is unknown whether KDF1 is involved in the pathogenesis of malignancy. No study has reported the expression and function of KDF1 in renal cancer. To explore the pathologic significance of KDF1 in clear cell renal cell carcinoma (ccRCC), the expression level of KDF1 protein in the tumor tissue of ccRCC patients was examined by immunohistochemistry and Western blot while the expression level of KDF1 mRNA was analyzed by using the data from TCGA database. In vitro cell experiments and allogeneic tumor transplantation tests were performed to determine the effects of altered KDF1 expression on the phenotype of ccRCC cells. Both the KDF1 mRNA and protein were found to be decreasingly expressed in the tumor tissue of ccRCC patients when compared with the adjacent non-tumor control tissue. The expression level of KDF1 in the tumor tissue was found to correlate negatively with the tumor grade. Patients with higher KDF1 in the tumor tissue were found to have longer overall survival and disease-specific survival time. KDF1 was shown to be an independent factor influencing the disease-specific survival of the ccRCC patients. Overexpression of KDF1 was found to inhibit the proliferation, migration and invasion of ccRCC cells, which could be reversed by decreasing the expression of KDF1 again. ccRCC cells with KDF1 overexpression were found to produce smaller transgrafted tumors. These results support the idea that KDF1 is involved in ccRCC and may function as a tumor suppressor.https://www.frontiersin.org/articles/10.3389/fonc.2021.686678/fullKDF1clear cell renal cell carcinomatumor gradetumor suppressorprognosis
collection DOAJ
language English
format Article
sources DOAJ
author Jing-min Zheng
Jing-min Zheng
Mei-fu Gan
Hong-yuan Yu
Lu-xia Ye
Qing-xin Yu
Yu-hui Xia
Han-xi Zhou
Jia-qian Bao
Yi-qing Guo
spellingShingle Jing-min Zheng
Jing-min Zheng
Mei-fu Gan
Hong-yuan Yu
Lu-xia Ye
Qing-xin Yu
Yu-hui Xia
Han-xi Zhou
Jia-qian Bao
Yi-qing Guo
KDF1, a Novel Tumor Suppressor in Clear Cell Renal Cell Carcinoma
Frontiers in Oncology
KDF1
clear cell renal cell carcinoma
tumor grade
tumor suppressor
prognosis
author_facet Jing-min Zheng
Jing-min Zheng
Mei-fu Gan
Hong-yuan Yu
Lu-xia Ye
Qing-xin Yu
Yu-hui Xia
Han-xi Zhou
Jia-qian Bao
Yi-qing Guo
author_sort Jing-min Zheng
title KDF1, a Novel Tumor Suppressor in Clear Cell Renal Cell Carcinoma
title_short KDF1, a Novel Tumor Suppressor in Clear Cell Renal Cell Carcinoma
title_full KDF1, a Novel Tumor Suppressor in Clear Cell Renal Cell Carcinoma
title_fullStr KDF1, a Novel Tumor Suppressor in Clear Cell Renal Cell Carcinoma
title_full_unstemmed KDF1, a Novel Tumor Suppressor in Clear Cell Renal Cell Carcinoma
title_sort kdf1, a novel tumor suppressor in clear cell renal cell carcinoma
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-05-01
description KDF1 has been identified as a key regulator of epidermal proliferation and differentiation, but it is unknown whether KDF1 is involved in the pathogenesis of malignancy. No study has reported the expression and function of KDF1 in renal cancer. To explore the pathologic significance of KDF1 in clear cell renal cell carcinoma (ccRCC), the expression level of KDF1 protein in the tumor tissue of ccRCC patients was examined by immunohistochemistry and Western blot while the expression level of KDF1 mRNA was analyzed by using the data from TCGA database. In vitro cell experiments and allogeneic tumor transplantation tests were performed to determine the effects of altered KDF1 expression on the phenotype of ccRCC cells. Both the KDF1 mRNA and protein were found to be decreasingly expressed in the tumor tissue of ccRCC patients when compared with the adjacent non-tumor control tissue. The expression level of KDF1 in the tumor tissue was found to correlate negatively with the tumor grade. Patients with higher KDF1 in the tumor tissue were found to have longer overall survival and disease-specific survival time. KDF1 was shown to be an independent factor influencing the disease-specific survival of the ccRCC patients. Overexpression of KDF1 was found to inhibit the proliferation, migration and invasion of ccRCC cells, which could be reversed by decreasing the expression of KDF1 again. ccRCC cells with KDF1 overexpression were found to produce smaller transgrafted tumors. These results support the idea that KDF1 is involved in ccRCC and may function as a tumor suppressor.
topic KDF1
clear cell renal cell carcinoma
tumor grade
tumor suppressor
prognosis
url https://www.frontiersin.org/articles/10.3389/fonc.2021.686678/full
work_keys_str_mv AT jingminzheng kdf1anoveltumorsuppressorinclearcellrenalcellcarcinoma
AT jingminzheng kdf1anoveltumorsuppressorinclearcellrenalcellcarcinoma
AT meifugan kdf1anoveltumorsuppressorinclearcellrenalcellcarcinoma
AT hongyuanyu kdf1anoveltumorsuppressorinclearcellrenalcellcarcinoma
AT luxiaye kdf1anoveltumorsuppressorinclearcellrenalcellcarcinoma
AT qingxinyu kdf1anoveltumorsuppressorinclearcellrenalcellcarcinoma
AT yuhuixia kdf1anoveltumorsuppressorinclearcellrenalcellcarcinoma
AT hanxizhou kdf1anoveltumorsuppressorinclearcellrenalcellcarcinoma
AT jiaqianbao kdf1anoveltumorsuppressorinclearcellrenalcellcarcinoma
AT yiqingguo kdf1anoveltumorsuppressorinclearcellrenalcellcarcinoma
_version_ 1721419321336397824